<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anesthesia for the child with asthma or recurrent wheezing
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anesthesia for the child with asthma or recurrent wheezing
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anesthesia for the child with asthma or recurrent wheezing
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Britta Regli-von Ungern-Sternberg, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Adrian Regli, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Andrew Davidson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marianna Crowley, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 30, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H26418773">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asthma is a chronic inflammatory lung disease characterized by symptoms of cough, wheezing, dyspnea and chest tightness, partially or completely reversible airway narrowing, and increased airway responsiveness to a variety of stimuli. Increased airway responsiveness is also seen in children with recurrent acute wheezing due to causes other than asthma (eg, allergies, viral infections). Asthma and recurrent wheezing are common childhood illnesses; pediatric patients with these conditions commonly present for anesthesia and surgery and can pose challenges for the anesthesiologist. Children with these conditions are at increased risk for perioperative respiratory adverse events, including laryngospasm and bronchospasm.
        </p>
        <p>
         Wheezing can occur at any time during anesthesia, most commonly during induction of general anesthesia after endotracheal intubation. If it occurs, it is usually transient and without sequelae if treated. However, bronchospasm can be severe and can result in significant morbidity and mortality.
        </p>
        <p>
         This topic will discuss preoperative assessment and preparation of pediatric patients with asthma and recurrent wheezing, as well as intraoperative management. Evaluation and management of asthma in children is discussed in more depth separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5742.html" rel="external">
          "Asthma in children younger than 12 years: Initial evaluation and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90904.html" rel="external">
          "Asthma in children younger than 12 years: Overview of initiating therapy and monitoring control"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5752.html" rel="external">
          "Evaluation of wheezing in infants and children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1410379632">
         <span class="h1">
          PREOPERATIVE EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         When possible, we prefer to assess patients with asthma one to two weeks prior to elective surgery to allow time for modification of treatment, if necessary. The goal of preoperative preparation is optimization of therapy to reduce the risk of perioperative respiratory adverse events (PRAE).
        </p>
        <p class="headingAnchor" id="H1410379839">
         <span class="h2">
          Asthma severity and control
         </span>
         <span class="headingEndMark">
          —
         </span>
         The history given by the patient or caregiver at the time of preoperative evaluation can help determine the severity and level of medical control of asthma and predict the likelihood of perioperative bronchospasm. Important historical points to emphasize during preoperative evaluation, in addition to a complete preoperative history, include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severity of asthma as assessed by patient or caregiver
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Triggering factors
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Personal or family history of allergies and atopy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Passive or active cigarette smoke inhalation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frequency and type of asthma medication use for maintenance and rescue
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dose, frequency, and most recent use of oral glucocorticoids
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of hospitalizations, intubations, and/or emergency department visits
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recent upper respiratory infection (URI), sinus infection, nocturnal cough, or fever
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baseline and current peak expiratory flow or FEV
         <sub>
          1
         </sub>
         if applicable
        </p>
        <p>
        </p>
        <p>
         Using this information, the level of control of asthma is classified as well controlled, not well controlled, or very poorly controlled. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Adjusting controller medication'
         </a>
         .)
        </p>
        <p>
         Any patient with asthma that is not well controlled should be referred to the appropriate clinician, primary care physician, or asthma specialist for treatment optimization prior to elective surgery. Further information about the assessment of asthma control is presented in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Symptom and risk assessment'
         </a>
         .)
        </p>
        <p>
         National and international organizations have developed guidelines that suggest a stepwise approach to the treatment of asthma in children. Patients are placed on a step that prescribes preferred and alternative medications, based on severity and control of symptoms, and can move up or down steps as disease worsens or improves.
        </p>
        <p>
         Medical management typically starts with intermittent or daily inhaled glucocorticoids whenever a short acting beta
         <sub>
          2
         </sub>
         agonist is used, progressing as necessary with increasing doses of inhaled glucocorticoids and the addition of long-acting beta
         <sub>
          2
         </sub>
         agonists (LABA), long-acting muscarinic agonists, anti-IgE, anti-IL5/5R, antiIL4R, leukotriene receptor antagonists, methylxanthines, and oral glucocorticoids.(See
         <a class="medical medical_review" href="/z/d/html/90904.html" rel="external">
          "Asthma in children younger than 12 years: Overview of initiating therapy and monitoring control"
         </a>
         .)
        </p>
        <p>
         Wheezing is a known risk factor for PRAE. In a large cohort study of 9287 children undergoing general anesthesia, perioperative bronchospasm and laryngospasm were encountered in 2.1 and 3.8 percent, respectively [
         <a href="#rid1">
          1
         </a>
         ]. A positive respiratory history (URI in the last two weeks, nocturnal dry cough, wheezing during exercise, or wheezing more than three times in the past 12 months) was associated with an increased risk of bronchospasm, perioperative cough, desaturation, or airway obstruction. URI was associated with PRAE only if present at the time of anesthesia or less than two weeks prior to the procedure. A history of current or past eczema as well as a family history of two family members with asthma, eczema, hayfever, or smoking increased the risk of PRAE as well. Risk factors for PRAE are shown in table  (
         <a class="graphic graphic_table graphicRef99883" href="/z/d/graphic/99883.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/91498.html" rel="external">
          "Anesthesia for the child with a recent upper respiratory infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1410380150">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preoperative physical examination for patients with asthma should focus on respiratory rate, wheezing, signs of lung infection, and air movement. The patient should ideally not be wheezing at the time of anesthesia. Baseline pulse oximetry value should be noted.
        </p>
        <p class="headingAnchor" id="H1410380157">
         <span class="h2">
          Preoperative testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who have well controlled asthma that is not steroid-dependent generally do not need additional testing beyond that which is performed for patients without asthma.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary function testing
         </strong>
         – Younger children (eg, younger than five years) are often not capable of performing most techniques necessary for pulmonary function testing. Spirometry and measurement of peak flow rate can be used in the office setting for older children and may be useful preoperatively if the degree of asthma control is in question.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory testing
         </strong>
         – Preoperative blood tests are rarely required and should only be performed as they would be for patients without asthma. However, patients who have taken oral glucocorticoids may be at risk for suppression of the hypothalamic pituitary axis (HPA) and adrenal insufficiency with the stress of surgery. Children who have been taking more than 5 mg/day of
         <a class="drug drug_pediatric" data-topicid="12725" href="/z/d/drug information/12725.html" rel="external">
          prednisone
         </a>
         for more than three weeks in the past year should either have the hypothalamic pituitary axis evaluated or, more commonly, should receive stress dose steroids prior to induction of anesthesia. HPA suppression in patients taking glucocorticoids and stress dose glucocorticoids are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5825.html" rel="external">
          "Treatment of adrenal insufficiency in children", section on 'Surgical procedures'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/146.html" rel="external">
          "The management of the surgical patient taking glucocorticoids"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Therapy with inhaled glucocorticoids can also affect HPA function, but the effects seem to be infrequent and largely subclinical. For children receiving inhaled glucocorticoid therapy within the recommended ranges, the risk of symptomatic adrenal suppression or acute adrenal crisis appears to be very small. Adrenal suppression with use of inhaled glucocorticoids is discussed more fully separately. (See
         <a class="medical medical_review" href="/z/d/html/540.html" rel="external">
          "Major side effects of inhaled glucocorticoids", section on 'Adrenal suppression'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arterial blood gas testing
         </strong>
         – Preoperative arterial blood gas testing is not routinely indicated, though it may be useful during a severe asthma attack.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest radiograph
         </strong>
         – Chest radiograph may show signs of hyperinflation but is not routinely indicated unless looking for signs of pulmonary infection or barotrauma.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1410380176">
         <span class="h1">
          PREOPERATIVE MEDICATION MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H1410380250">
         <span class="h2">
          Maintenance medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with asthma should continue all of their usual medication up to and including the day of surgery. The exception is
         <a class="drug drug_pediatric" data-topicid="12831" href="/z/d/drug information/12831.html" rel="external">
          theophylline
         </a>
         , which should be discontinued the evening prior to surgery because of the risk of cardiac arrhythmias [
         <a href="#rid2">
          2
         </a>
         ]. Continuation of inhaled medications, including inhaled glucocorticoids, has been shown to reduce the incidence of postoperative pulmonary complications [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4814.html" rel="external">
          "Perioperative medication management", section on 'Pulmonary agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1410380256">
         <span class="h2">
          Supplemental glucocorticoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Supplemental glucocorticoids should be given in consultation with a pulmonary or primary care clinician. Preoperative inhaled glucocorticoids should be administered for children with not well controlled asthma and who are not currently receiving inhaled glucocorticoids.
        </p>
        <p>
         For children with very poorly controlled asthma requiring endotracheal intubation, we suggest a course of supplemental systemic glucocorticoid. In this setting, we usually administer
         <a class="drug drug_pediatric" data-topicid="12725" href="/z/d/drug information/12725.html" rel="external">
          prednisone
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12723" href="/z/d/drug information/12723.html" rel="external">
          prednisolone
         </a>
         orally 1 mg/kg (maximum 50 mg) once a day for 3 to 10 days. Intravenous (IV)
         <a class="drug drug_pediatric" data-topicid="13361" href="/z/d/drug information/13361.html" rel="external">
          hydrocortisone
         </a>
         (4 mg/kg, maximum 100 mg, every six hours) or
         <a class="drug drug_pediatric" data-topicid="12601" href="/z/d/drug information/12601.html" rel="external">
          methylprednisolone
         </a>
         (1 to 2 mg/kg, maximum 125 mg, once daily) are acceptable alternatives for patients unable to tolerate oral medications.
        </p>
        <p>
         In adults, preoperative systemic glucocorticoids may improve lung function and reduce the bronchoconstrictive response to endotracheal intubation [
         <a href="#rid4">
          4
         </a>
         ]. In addition, a number of studies have shown that systemic glucocorticoids do not increase postoperative wound infections, delayed wound healing, or asthma exacerbations [
         <a href="#rid4">
          4-6
         </a>
         ]. However, there are no specific pediatric data.
        </p>
        <p class="headingAnchor" id="H525814208">
         <span class="h1">
          PREMEDICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchodilators are routinely administered to children with asthma prior to endotracheal intubation. We do not routinely premedicate children with asthma with sedatives.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inhaled bronchodilators
         </strong>
         – Children with asthma should receive inhaled short-acting beta
         <sub>
          2
         </sub>
         agonist (SABA) treatment 20 to 30 minutes prior to induction of anesthesia (
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         , via nebulizer 2.5 mg if &lt;20 kg, 5 mg if &gt;20 kg, or via metered dose inhaler [MDI] with spacer, two to eight puffs) [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additionally, preoperative SABA may reduce perioperative respiratory adverse events (PRAE) in children undergoing tonsillectomy [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94216.html" rel="external">
          "Anesthesia for tonsillectomy with or without adenoidectomy in children", section on 'Preoperative inhaled short-acting beta-2 agonist (SABA)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Benzodiazepines
         </strong>
         – Although benzodiazepines may be used in patients with asthma to reduce anxiety, they do not reduce the incidence of laryngospasm or bronchospasm with general anesthesia and are associated with an increased risk for desaturations and airway obstruction [
         <a href="#rid1">
          1
         </a>
         ]. We prefer to use distraction techniques (eg, toys, video games, stickers) prior to anesthesia for most pediatric patients, including those with asthma, rather than administration of sedatives.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alpha agonists
         </strong>
         – There are conflicting data regarding the use of alpha agonists, such as
         <a class="drug drug_pediatric" data-topicid="13171" href="/z/d/drug information/13171.html" rel="external">
          clonidine
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="13128" href="/z/d/drug information/13128.html" rel="external">
          dexmedetomidine
         </a>
         , for patients with asthma. Alpha agonists have been shown in animal studies to blunt reflex bronchoconstriction and might therefore be beneficial as premedication for children undergoing general anesthesia [
         <a href="#rid10">
          10-12
         </a>
         ]. In contrast, two small clinical trials in adults showed an increase in histamine-induced airway resistance following oral clonidine [
         <a href="#rid13">
          13,14
         </a>
         ]. Intranasal dexmedetomidine (3 mcg/kg) has been successfully used in agitated children with asthma [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26418821">
         <span class="h1">
          REGIONAL VERSUS GENERAL ANESTHESIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Airway management, particularly the use of an endotracheal tube, is a very potent stimulus for bronchoconstriction. When possible, avoidance of endotracheal intubation and instead the use of noninvasive airway devices (eg, supraglottic airway devices) decrease the chance of intraoperative bronchospasm and laryngospasm.
        </p>
        <p>
         While regional anesthesia avoids the need to manipulate the airway, it is rarely used in the pediatric population. When possible in older children, regional anesthesia is a good choice as it avoids the need to manipulate the airway. Regional anesthesia is discussed more fully separately. (See
         <a class="medical medical_review" href="/z/d/html/94358.html" rel="external">
          "Anesthesia for adult patients with asthma", section on 'Regional anesthesia'
         </a>
         .)
        </p>
        <p>
         General anesthesia is associated with increased risk of bronchospasm and laryngospasm compared with regional anesthesia. In this setting bronchospasm occurs most commonly because of mechanical stimulation of the airway. In addition, bronchospasm can result from histamine release, an allergic reaction to administered medication, or from vagal stimulation during surgery (eg, peritoneal insufflation during laparoscopy, manipulation of viscera, or endoscopy).
        </p>
        <p class="headingAnchor" id="H1269448">
         <span class="h1">
          STRATEGY FOR GENERAL ANESTHESIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of perioperative respiratory adverse events (PRAE), particularly for bronchospasm and laryngospasm, decreases with increasing experience in pediatric airway management [
         <a href="#rid1">
          1,16,17
         </a>
         ]. As such, we suggest that children with asthma are best managed by an experienced pediatric anesthesiologist. This is particularly true for those with additional risk factors for PRAE  (
         <a class="graphic graphic_table graphicRef99883" href="/z/d/graphic/99883.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H26418860">
         <span class="h2">
          Airway management
         </span>
         <span class="headingEndMark">
          —
         </span>
         One goal of induction of anesthesia in the patient with asthma is to minimize the risk of a bronchoconstrictive response to airway management. Since the risk of bronchospasm is lower with a laryngeal mask airway (LMA) or mask ventilation when compared with endotracheal intubation [
         <a href="#rid1">
          1,18-20
         </a>
         ], these less invasive devices should be used when possible rather than an endotracheal tube.
        </p>
        <p>
         If endotracheal intubation is planned, we use a cuffed endotracheal tube (ETT) as opposed to an uncuffed ETT for all children, but particularly if a child has an increased risk of developing bronchospasm or has poorly controlled asthma. The cuffed ETT allows the use of higher peak airway pressures during mechanical ventilation with less leakage around the ETT [
         <a href="#rid21">
          21,22
         </a>
         ]. A further advantage, irrespective of the presence of asthma, is that cuffed ETTs (when cuff pressure is well monitored) are associated with less perioperative laryngospasm, bronchospasm, and severe persistent coughing as well as less postoperative sore throat and hoarse voice [
         <a href="#rid22">
          22,23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/113570.html" rel="external">
          "Airway management for pediatric anesthesia", section on 'Cuffed versus uncuffed endotracheal tubes'
         </a>
         .)
        </p>
        <p>
         If endotracheal intubation is planned, we suggest the use of neuromuscular blocking agents for children with asthma, as this is associated with less PRAEs [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1269455">
         <span class="h2">
          Induction of anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Induction must achieve a depth of anesthesia sufficient to prevent physiologic response to airway manipulation. This is particularly important in the patient with asthma.
        </p>
        <p>
         Most intravenous (IV) and inhalation anesthesia induction agents blunt airway reflexes and produce bronchodilation in varying degrees. During induction of anesthesia and airway manipulation, the ability of a medication to suppress airway reflexes is of particular value. During maintenance of anesthesia, the bronchodilatory effect of a drug may be more important.
        </p>
        <p class="headingAnchor" id="H525814461">
         <span class="h3">
          Intravenous versus inhalation induction
         </span>
         <span class="headingEndMark">
          —
         </span>
         When possible and tolerated by the child, we suggest IV induction rather than inhalation induction for children at risk for PRAE, including children with asthma. Traditionally, inhalation induction has been performed in pediatric anesthesia; however, IV induction has gained widespread acceptance.
        </p>
        <p>
         The preponderance of available evidence suggests that IV induction is associated with reduced risk of perioperative PRAE in at risk children. In a single-center randomized trial including 300 children with two or more risk factors for PRAE (upper respiratory infection [URI] ≤2 weeks, wheezing ≤12 months, wheezing at exercise, nocturnal dry cough, past/present eczema, passive smoking, family history of hay fever/asthma/eczema) who underwent general anesthesia with a supraglottic airway, children who were assigned to inhalation induction with
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         were twice as likely to experience PRAE (ie, bronchospasm, laryngospasm, coughing, desaturation to &lt;95 percent, airway obstruction, or stridor) compared with those who were induced with
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         (43 versus 26 percent, relative risk [RR] 1.7, 95% CI 1.2-2.3) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         In support of these results, two large observational studies in children with and without risk factors for PRAE undergoing anesthesia found that IV induction was associated with fewer respiratory complications [
         <a href="#rid1">
          1,17
         </a>
         ]. In a single-center prospective observational study of PRAE (ie, bronchospasm, laryngospasm, coughing, desaturation to &lt;95 percent, airway obstruction, or stridor) in more than 9000 pediatric anesthetics, inhaled induction was associated with an increase in PRAE (20 versus 10 percent, RR 1.97, 95% CI 1.78-2.18) [
         <a href="#rid1">
          1
         </a>
         ]. Similarly, in the Anaesthesia PRactice In Children Observational Trial
         <strong>
          <em>
          </em>
         </strong>
         (APRICOT) study, a large prospective multi-institutional study of critical events in over 31,000 pediatric anesthetics, inhalation induction was associated with an increase in severe respiratory critical events, defined as laryngospasm, bronchospasm, or postoperative stridor (2.2 versus 3.6 percent, RR 0.85, 95%CI 0.74-0.98]) [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         A meta-analysis of four randomized trials including 588 children with and without known risk factors for PRAE who underwent general anesthesia did not demonstrate superiority of IV over inhaled induction with regards to rates of PRAE (RR 2.9, 95% CI 0.2-36.4) [
         <a href="#rid25">
          25
         </a>
         ]. There was high risk of bias due to lack of blinding in all studies, high clinical heterogeneity among studies, and high statistical heterogeneity for all outcomes.
        </p>
        <p class="headingAnchor" id="H525814532">
         <span class="h3">
          Lidocaine
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not routinely use IV
         <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">
          lidocaine
         </a>
         prior to endotracheal intubation of children with asthma. In adults, IV lidocaine (1 to 2 mg/kg) and inhaled lidocaine (nebulized 5 mg/kg in
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         ) have been shown to attenuate bronchial hyperreactivity, including in patients with asthma [
         <a href="#rid26">
          26-28
         </a>
         ], and in children, IV lidocaine (2 mg/kg IV) has been shown to transiently reduce the incidence of laryngospasm with vocal cord irritation [
         <a href="#rid29">
          29
         </a>
         ]. However, inhaled lidocaine initially causes bronchoconstriction in patients with asthma and can cause cough and laryngospasm [
         <a href="#rid30">
          30-32
         </a>
         ]. We do not recommend the use of topical lidocaine in children prior to endotracheal intubation without neuromuscular blockade, as this has been shown to increase desaturations without reducing the incidence of bronchospasm or laryngospasm [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H525814468">
         <span class="h3">
          Intravenous induction agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         While
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         is the induction agent of choice for most children with asthma, certain clinical scenarios may warrant the use of other agents. Both propofol and
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         are bronchodilatory agents. IV induction of anesthesia in children is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/106984.html" rel="external">
          "General anesthesia in neonates and children: Agents and techniques", section on 'IV induction'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          Propofol
         </a>
         – We suggest using propofol for induction for the hemodynamically stable patient with asthma, as it has been shown to attenuate the bronchospastic response to intubation in both patients with and without asthma [
         <a href="#rid34">
          34,35
         </a>
         ]. There are a number of case reports of significant bronchospasm with propofol use in patients allergic to the active components of the drug, the soybean oil or egg phosphatide in the propofol preparation, or, in some preparations, the sodium metabisulfite used as a preservative [
         <a href="#rid34">
          34,36,37
         </a>
         ]. However, propofol appears safe even in children with egg allergy if there is no history of anaphylaxis [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          Ketamine
         </a>
         – Ketamine has sympathomimetic bronchodilatory properties and blocks reflex bronchoconstriction, making it useful for induction, particularly in the hemodynamically unstable patient [
         <a href="#rid39">
          39
         </a>
         ]. Ketamine-induced bronchodilation may not be as pronounced as that of
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         [
         <a href="#rid40">
          40,41
         </a>
         ], though this has not been studied in children. The use of ketamine in addition to standard asthma treatment has not been shown to be of benefit in children with acute asthma exacerbation in the emergency department setting [
         <a href="#rid42">
          42,43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="12907" href="/z/d/drug information/12907.html" rel="external">
          Etomidate
         </a>
         – Etomidate can be used for induction in patients with asthma, but it lacks the bronchodilatory effects of
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         [
         <a href="#rid34">
          34
         </a>
         ]. Etomidate might be useful for induction of hemodynamically unstable patients. However, there is a risk of adrenal insufficiency in critically ill patients after an induction dose of etomidate [
         <a href="#rid44">
          44
         </a>
         ]. Etomidate is not available in some countries (eg, Australia).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Barbiturates
         </strong>
         – Thiopental, which is no longer available in the United States, releases histamine and has been shown to cause higher airway resistance compared with
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         [
         <a href="#rid34">
          34,41
         </a>
         ].
         <a class="drug drug_pediatric" data-topicid="12594" href="/z/d/drug information/12594.html" rel="external">
          Methohexital
         </a>
         does not release histamine and can be used as an alternative to the induction agents discussed. However bronchoconstriction in response to endotracheal intubation is more common with induction with methohexital than with propofol [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21055688">
         <span class="h2">
          Maintenance of anesthesia
         </span>
        </p>
        <p class="headingAnchor" id="H21055695">
         <span class="h3">
          Anesthetic agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         For most patients with asthma, total IV anesthesia (TIVA),
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         ,
         <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">
          isoflurane
         </a>
         , or halothane can safely be used for maintenance of anesthesia.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21056041">
         <span class="h4">
          Inhalation agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most potent or volatile inhalation anesthetic agents (eg,
         <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">
          isoflurane
         </a>
         ,
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         , and halothane) are bronchodilators, decrease airway responsiveness, and attenuate bronchospasm [
         <a href="#rid45">
          45
         </a>
         ]. However, volatile anesthetic agents only have a limited ability to blunt reflex bronchoconstriction [
         <a href="#rid46">
          46,47
         </a>
         ]. Attenuation of these reflexes is particularly important in children with asthma in order to avoid PRAE [
         <a href="#rid46">
          46,47
         </a>
         ]. Volatile anesthetic agents have been used to treat status asthmaticus [
         <a href="#rid48">
          48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Delivery of inhaled medications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Of the volatile agents,
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         is generally preferred for patients with asthma because it is the most effective bronchodilator. Where available, halothane is an acceptable alternative.
         <a class="drug drug_pediatric" data-topicid="134454" href="/z/d/drug information/134454.html" rel="external">
          Desflurane
         </a>
         is an extremely pungent volatile anesthetic and can produce an increase in secretions, coughing, airway resistance, and laryngospasm [
         <a href="#rid49">
          49-51
         </a>
         ]. Desflurane should not be used in children with asthma or risk factors for PRAE since it significantly increases airway resistance and the incidence of PRAE in the pediatric population.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          Nitrous oxide
         </a>
         is a relatively weak inhaled anesthetic that is often used in conjunction with other anesthetics for general anesthesia in much higher concentration than the volatile agents. It is not an airway irritant but is also not a bronchodilator [
         <a href="#rid45">
          45
         </a>
         ]. It can be used safely in patients with asthma who have no other contraindication to its use and who do not require 100 percent oxygen.
        </p>
        <p class="headingAnchor" id="H21056075">
         <span class="h4">
          Intravenous agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         IV anesthetic medications may be used by either bolus or infusion along with inhalation agents, or as part of a TIVA. Combinations of
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13171" href="/z/d/drug information/13171.html" rel="external">
          clonidine
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="13128" href="/z/d/drug information/13128.html" rel="external">
          dexmedetomidine
         </a>
         , as well as a variety of opioids, are used in this way. There are no studies that establish the benefits of combinations of these medications in asthma, but each of them in isolation has been shown to be safe or beneficial. Dexmedetomidine, an alpha
         <sub>
          2
         </sub>
         agonist, has been shown to protect against histamine-induced bronchoconstriction in dogs [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21056173">
         <span class="h3">
          Neuromuscular blocking agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuromuscular blocking agents are the most common cause of intraoperative allergic (IgE-mediated) and nonallergic reactions, which may cause bronchospasm through histamine liberation. Mivacurium and
         <a class="drug drug_pediatric" data-topicid="12862" href="/z/d/drug information/12862.html" rel="external">
          atracurium
         </a>
         release histamine, though bronchospasm as a result is very rare [
         <a href="#rid52">
          52
         </a>
         ]. The more commonly used relaxants (
         <a class="drug drug_pediatric" data-topicid="12774" href="/z/d/drug information/12774.html" rel="external">
          rocuronium
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12877" href="/z/d/drug information/12877.html" rel="external">
          vecuronium
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="13160" href="/z/d/drug information/13160.html" rel="external">
          cisatracurium
         </a>
         ) and the less commonly used
         <a class="drug drug_pediatric" data-topicid="12676" href="/z/d/drug information/12676.html" rel="external">
          pancuronium
         </a>
         do not release appreciable amounts of histamine. Rocuronium and
         <a class="drug drug_pediatric" data-topicid="12809" href="/z/d/drug information/12809.html" rel="external">
          succinylcholine
         </a>
         are the most commonly used agents associated with IgE-mediated allergic reactions [
         <a href="#rid53">
          53
         </a>
         ]. Succinylcholine releases low levels of histamine and has been used safely in patients with asthma [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
         Reversal of neuromuscular blocking agents with anticholinesterase agents such as
         <a class="drug drug_pediatric" data-topicid="12640" href="/z/d/drug information/12640.html" rel="external">
          neostigmine
         </a>
         can cause an increase in bronchial secretions and airway reactivity and can trigger bronchospasm [
         <a href="#rid55">
          55
         </a>
         ], though this is rare. Neostigmine is administered with anticholinergic medication, either
         <a class="drug drug_pediatric" data-topicid="13338" href="/z/d/drug information/13338.html" rel="external">
          glycopyrrolate
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         , to block the muscarinic receptors responsible for this effect.
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="107775" href="/z/d/drug information/107775.html" rel="external">
          Sugammadex
         </a>
         , a newer drug used for the reversal of muscle relaxants, works by encapsulation of steroidal neuromuscular blockers and is devoid of muscarinic and bronchial smooth muscle effects [
         <a href="#rid56">
          56
         </a>
         ]. However, a study of the use of sugammadex in patients with pulmonary disease showed a 2.6 percent incidence of bronchospasm and should therefore be used cautiously [
         <a href="#rid57">
          57,58
         </a>
         ]. Sugammadex is also associated with a dose dependent incidence of anaphylaxis [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21056315">
         <span class="h3">
          Opioids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Synthetic opioids are generally preferred for patients with asthma, though data are lacking to suggest that any particular opioid is safer for children with asthma. Almost all opioids release some amount of histamine and can thus theoretically cause bronchospasm.
         <a class="drug drug_pediatric" data-topicid="16024" href="/z/d/drug information/16024.html" rel="external">
          Morphine
         </a>
         in particular can release histamine and cause bronchospasm, especially if given rapidly and in large doses [
         <a href="#rid60">
          60,61
         </a>
         ], though in some patients morphine has been shown to blunt reflex bronchoconstriction [
         <a href="#rid62">
          62
         </a>
         ]. Synthetic opioids (ie,
         <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">
          fentanyl
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12812" href="/z/d/drug information/12812.html" rel="external">
          sufentanil
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12998" href="/z/d/drug information/12998.html" rel="external">
          remifentanil
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="13364" href="/z/d/drug information/13364.html" rel="external">
          hydromorphone
         </a>
         ) tend to release much less histamine, and have all been used safely in patients with asthma [
         <a href="#rid63">
          63,64
         </a>
         ]. An exception is
         <a class="drug drug_pediatric" data-topicid="12580" href="/z/d/drug information/12580.html" rel="external">
          meperidine
         </a>
         , a synthetic opioid which can release relatively high levels [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20389437">
         <span class="h3">
          Beta blockers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Beta blockers are only rarely used in pediatric anesthesia and should be used cautiously in patients with asthma. When required, the lowest possible dose of a beta
         <sub>
          1
         </sub>
         -selective agent should be administered.
        </p>
        <p>
         Beta blockade with nonselective drugs, which are those that block both beta
         <sub>
          1
         </sub>
         and beta
         <sub>
          2
         </sub>
         receptors, can cause bronchospasm because of their beta
         <sub>
          2
         </sub>
         -blocking effects and may reduce the efficacy of beta agonist medication.
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="13279" href="/z/d/drug information/13279.html" rel="external">
          Esmolol
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="12605" href="/z/d/drug information/12605.html" rel="external">
          metoprolol
         </a>
         , two beta
         <sub>
          1
         </sub>
         -selective drugs that are commonly used under anesthesia, are much less likely to cause bronchospasm, though at high doses their selectivity may diminish. [
         <a href="#rid66">
          66
         </a>
         ]
         <a class="drug drug_pediatric" data-topicid="13403" href="/z/d/drug information/13403.html" rel="external">
          Labetalol
         </a>
         , a combined beta and alpha blocker, is even less likely to cause bronchospasm [
         <a href="#rid67">
          67
         </a>
         ]. The use of beta blockers in patients with asthma is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/967.html" rel="external">
          "Major side effects of beta blockers", section on 'Increased airways resistance'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20389450">
         <span class="h2">
          Ventilation during anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ventilatory strategy for patients with asthma during anesthesia that requires controlled ventilation should be designed to reduce air trapping [
         <a href="#rid68">
          68,69
         </a>
         ]. Even during bag mask ventilation, patients with airflow obstruction need prolonged expiration. Stacked breaths, which occur when a breath starts before the prior exhalation is complete, can result in air trapping, hyperinflation, and, in the extreme, barotrauma. Reduction of the inspiratory/expiratory ratio is an important strategy to reduce air trapping, but the most effective maneuver is to reduce minute ventilation by reducing both rate and tidal volume [
         <a href="#rid68">
          68
         </a>
         ]. This strategy may require permissive hypercapnia; ie, acceptance of a higher than normal end-tidal CO
         <sub>
          2
         </sub>
         or PCO
         <sub>
          2
         </sub>
         . (See
         <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Ventilation strategy'
         </a>
         .)
        </p>
        <p>
         For children with well controlled asthma and no signs of bronchospasm under anesthesia, ventilatory strategy should be the same as for children without asthma. If there are any signs of bronchospasm, the following initial ventilator settings should be used, modified in response to the clinical situation (see
         <a class="local">
          'Identification'
         </a>
         below):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tidal volume of 6 to 8 mL/kg
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory rate near or below physiologic rate
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         I:E ratio to prevent breath stacking, approximately 1:4
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Positive end-expiratory pressure (PEEP) of 3 to 5 cm H
         <sub>
          2
         </sub>
         O
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Peak airway pressure &lt;50 cm H
         <sub>
          2
         </sub>
         O; plateau pressure &lt;35 cm H
         <sub>
          2
         </sub>
         O
        </p>
        <p>
        </p>
        <p>
         Increased alveolar pressure is associated with an increased incidence of barotrauma, but peak inspiratory pressures do not reliably reflect plateau pressures or alveolar pressures in the presence of severe airflow obstruction.
        </p>
        <p>
         If possible, the flow time curve should be assessed and the ventilator settings (eg, respiratory rate and expiratory time) should be modified to allow expiratory flow to return as close to baseline as possible [
         <a href="#rid70">
          70,71
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20389622">
         <span class="h1">
          INTRAOPERATIVE BRONCHOSPASM
         </span>
        </p>
        <p class="headingAnchor" id="H3707579859">
         <span class="h2">
          Incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         The reported incidence of intraoperative bronchospasm in children is between 0.3 and 3.2 percent [
         <a href="#rid1">
          1,17
         </a>
         ]. In the Anaesthesia PRactice In Children Observational Trial
         <strong>
          <em>
          </em>
         </strong>
         (APRICOT) study, a prospective observational study of critical events in 30,874 children &lt;15 years of age who underwent anesthesia in 261 hospitals throughout Europe, there was wide variation in the incidence of bronchospasm across centers, between 0.3 to 3.2 percent [
         <a href="#rid17">
          17
         </a>
         ]. Ninety six percent of cases of bronchospasm occurred in the operating room, rather than in the post-anesthesia care unit.
        </p>
        <p class="headingAnchor" id="H20389628">
         <span class="h2">
          Identification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Signs of bronchospasm under anesthesia include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wheezing on chest auscultation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Slow or incomplete expiration on inspection
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Change in end-tidal carbon dioxide (EtCO
         <sub>
          2
         </sub>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Upsloping EtCO
         <sub>
          2
         </sub>
         waveform
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe: decreased value, or absent EtCO
         <sub>
          2
         </sub>
         waveform
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased tidal volume
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         High inspiratory pressure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreasing oxygen saturation
        </p>
        <p>
        </p>
        <p>
         Nonbronchospastic causes of the above findings should be ruled out, while setting FiO
         <sub>
          2
         </sub>
         to 100 percent and changing to hand ventilation to assess compliance and exhalation. During bronchospasm, compliance is decreased, and exhalation is prolonged. The following may mimic bronchospasm and are suggested by these clinical findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Endobronchial intubation
         </strong>
         – Decreased breath sounds on one side (usually left) and a deep endotracheal tube; asymmetric chest rise.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pneumothorax
         </strong>
         – Decreased breath sounds on one side; asymmetric chest rise; tracheal deviation away from pneumothorax, particularly if high respiratory rate in combination with high tidal volumes have been used or clinical scenario, making pneumothorax likely (eg, trauma, diaphragm injury).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary edema
         </strong>
         – Frothy secretions in the endotracheal tube; crackles on pulmonary exam.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Kinked or obstructed endotracheal tube
         </strong>
         – Difficulty passing suction catheter and/or removal of secretions upon suctioning.
        </p>
        <p>
        </p>
        <p>
         Bronchospasm may be part of an anaphylactic reaction. Signs that suggest anaphylaxis include hypotension, tachycardia, and rash. The management of anaphylaxis is presented separately  (
         <a class="graphic graphic_table graphicRef74242" href="/z/d/graphic/74242.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment", section on 'Immediate management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H187476331">
         <span class="h2">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         When bronchospasm is suspected, initial management includes administration of 100 percent oxygen and careful hand ventilation (slow respiratory rate and sufficient expiratory time to avoid barotrauma). Mild bronchospasm is commonly treated by deepening the anesthetic. This can be accomplished by administering a bolus of
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         or by deepening the level of inhaled anesthetic.
        </p>
        <p>
         Patients with bronchospasm that persists after deepening the anesthesia should receive short-acting beta agonist therapy. A rapidly acting beta
         <sub>
          2
         </sub>
         agonist such as
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         (salbutamol) should be administered by metered dose inhaler (MDI) via the endotracheal tube with an adapter. Eight to 10 puffs of short-acting beta
         <sub>
          2
         </sub>
         agonist (SABA) therapy should be used since much of the medication will condense in the endotracheal tube.
        </p>
        <p>
         In spontaneously breathing, unintubated children, the optimal method for administration of inhaled medication for the treatment of bronchospasm is via a pressurized MDI (pMDI) with a spacer, while the optimal method for aerosol delivery in mechanically ventilated patients is less clear [
         <a href="#rid72">
          72-74
         </a>
         ]. Much of the medication delivered by MDI condenses in the endotracheal tube or breathing circuit. In addition, the use of a small-sized ETT reduces the amount of drug reaching the lungs. A 10-fold greater dose of aerosol is required to provide a clinical effect when an MDI is used in an intubated patient, as compared with the doses used in an unintubated patient. It has been estimated that &lt;3 percent of the drug dose is delivered to the bronchial site of action with use of an MDI when an endotracheal tube is in place [
         <a href="#rid75">
          75
         </a>
         ]. Aerosol administration via the actuator of an MDI directly connected to the ETT may result in greater drug delivery to the lower airways compared with the use of an inline adaptor or a 50 mL Luer-Lok syringe [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         More severe bronchospasm requires further intervention with one or more of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Volatile anesthetic agents
         </strong>
         – Except for
         <a class="drug drug_pediatric" data-topicid="134454" href="/z/d/drug information/134454.html" rel="external">
          desflurane
         </a>
         , volatile anesthetic agents are excellent bronchodilators and have been successfully used to treat status asthmaticus [
         <a href="#rid48">
          48
         </a>
         ]. The fastest and easiest intraoperative treatment is to increase the concentration of volatile anesthetics. (See
         <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Delivery of inhaled medications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anticholinergics
         </strong>
         –
         <a class="drug drug_pediatric" data-topicid="13338" href="/z/d/drug information/13338.html" rel="external">
          Glycopyrrolate
         </a>
         (4 mcg/kg intravenous [IV]),
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         (20 mcg/kg IV), and
         <a class="drug drug_pediatric" data-topicid="13389" href="/z/d/drug information/13389.html" rel="external">
          ipratropium
         </a>
         (250 to 500 mcg by nebulizer or four to eight puffs 18 mcg/puff via MDI) have bronchodilatory properties. When compared with atropine, glycopyrrolate produces bronchodilation of longer duration (&gt;4 hours versus 3 to 4 hours) [
         <a href="#rid77">
          77
         </a>
         ]. Onset of effect takes 20 to 30 minutes, so anticholinergic use should be combined with a more rapidly acting treatment, such as
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         . IV anticholinergics often cause significant tachycardia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13272" href="/z/d/drug information/13272.html" rel="external">
          Epinephrine
         </a>
         – For refractory bronchospasm, and especially if anaphylaxis is suspected, epinephrine should be administered. Standard dosing for intramuscular (IM) administration is 0.01 mL/kg of a 1 mg/mL solution, maximum dose 0.4 mg or 0.4 mL administered IM into the mid-outer thigh (vastus lateralis muscle), which can be repeated at 5 to 15 minute intervals. When IV access has been established, an epinephrine infusion may be started at 0.1 to 1 mcg/kg/minute via infusion pump, monitoring for tachycardia and hypertension. If continued infusion is required, central venous access should be established for administration. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment", section on 'Dosing and administration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For cases of severe, refractory bronchospasm when cardiac arrest is imminent,
         <a class="drug drug_pediatric" data-topicid="13272" href="/z/d/drug information/13272.html" rel="external">
          epinephrine
         </a>
         should be administered by IV bolus, starting with 10 mcg IV, escalating as needed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intravenous SABA
         </strong>
         – In cases of severe bronchospasm refractory to other therapies,
         <strong>
         </strong>
         we administer IV
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         (salbutamol) 10 mcg/kg over 10 minutes followed by 1 to 5 mcg/kg/minute. IV albuterol is not available in the United States [
         <a href="#rid78">
          78,79
         </a>
         ]. IV
         <a class="drug drug_pediatric" data-topicid="12826" href="/z/d/drug information/12826.html" rel="external">
          terbutaline
         </a>
         can be administered. Bolus with 10 mcg/kg IV over 10 minutes, then 0.1 to 10 mcg/kg/minute; infusion may be increased by 0.1 to 1 mcg/kg/minute every 30 minutes to a maximum of 5 mcg/kg/minute. Side effects of IV SABA include tachycardia and dysrhythmias, hypotension, hyperglycemia, hypokalemia, and myocardial ischemia. (See
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Bronchodilators'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glucocorticoids
         </strong>
         – High-dose glucocorticoids
         <a class="drug drug_pediatric" data-topicid="13361" href="/z/d/drug information/13361.html" rel="external">
          hydrocortisone
         </a>
         4 mg/kg IV (maximum 100 mg) or IV
         <a class="drug drug_pediatric" data-topicid="12601" href="/z/d/drug information/12601.html" rel="external">
          methylprednisolone
         </a>
         (1 to 2 mg/kg, maximum 125 mg) will not be effective for four to six hours and should be combined with rapidly acting medication. Perioperative steroids have not been shown to increase surgical complications [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neuromuscular blocking agents
         </strong>
         – In cases of severe bronchospasm, neuromuscular blocking agents (NMBAs) may improve mechanics of ventilation and lower peak inspiratory pressures [
         <a href="#rid70">
          70,80
         </a>
         ]. An NMBA that does not release histamine should be chosen in this situation. (See
         <a class="local">
          'Intravenous agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="12982" href="/z/d/drug information/12982.html" rel="external">
          Magnesium sulfate
         </a>
         – Magnesium sulfate (40 mg/kg up to 2 g IV over 20 minutes in children &gt;2 years) may be helpful with difficult cases of bronchospasm, especially when given with inhaled beta
         <sub>
          2
         </sub>
         agonist and glucocorticoids. A meta-analysis supports its use in acute exacerbations of asthma [
         <a href="#rid81">
          81,82
         </a>
         ]. High doses and blood levels of magnesium produce skeletal muscle weakness and central nervous system depression. Magnesium may cause hypotension because of a reduction in systemic vascular resistance.
        </p>
        <p>
        </p>
        <p>
         Some interventions are controversial or have been described only in case reports for the adult population but are not commonly employed by anesthesiologists. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="12831" href="/z/d/drug information/12831.html" rel="external">
          Theophylline
         </a>
         – In a systematic review, IV theophylline had no benefit over IV SABAs [
         <a href="#rid79">
          79
         </a>
         ]. In contrast to volatile anesthetic agents, theophylline has narrow therapeutic window and is not readily available in the operating room environment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Heliox
         </strong>
         – Mixtures of helium and oxygen (heliox) have occasionally been used in cases of acute, severe bronchospasm. However, heliox can only provide a fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) of 21 to 30 percent and does not reverse bronchospasm, so it is used as a temporizing measure while bronchospasm is treated [
         <a href="#rid83">
          83
         </a>
         ]. In addition, technical constraints limit the ability to use heliox during anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/541.html" rel="external">
          "Physiology and clinical use of heliox"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Extracorporeal membrane oxygenation
         </strong>
         is reserved for the most severe bronchospasm that is refractory to maximal medical and mechanical ventilatory therapy. (See
         <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Extracorporeal membrane oxygenation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H187477029">
         <span class="h1">
          COMPLICATIONS OF BRONCHOSPASM
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with asthma are at risk for significant respiratory and cardiovascular complications during mechanical ventilation.
        </p>
        <p class="headingAnchor" id="H187477047">
         <span class="h2">
          Respiratory deterioration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypoxemia can develop as a result of worsening airflow obstruction, tension pneumothorax, or atelectasis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tension pneumothorax
         </strong>
         – Tension pneumothorax can occur with positive pressure ventilation, with mask ventilation, through a supraglottic airway device, or with an endotracheal tube. Signs of tension pneumothorax include asymmetrical breath sounds and chest rise, dullness to percussion, tracheal deviation away from pneumothorax, and high airway pressures, though these may not be sensitive signs in children. Hypotension can occur as a result of tension pneumothorax because of decreased venous return to the heart. If tension pneumothorax is suspected and the patient is unstable, a needle should be inserted in the second intercostal space in the midclavicular line to release the air. (See
         <a class="medical medical_review" href="/z/d/html/6706.html" rel="external">
          "Pneumothorax in adults: Epidemiology and etiology"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the patient is hemodynamically stable, chest radiograph should be performed to confirm the diagnosis of pneumothorax prior to chest tube placement.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atelectasis
         </strong>
         – Atelectasis is frequent in children with asthma due to mucus plugging in relatively small airway calibers. If atelectasis and hypoxia are severe, the patient might benefit from endobronchial suctioning. Suctioning should be done only when absolutely necessary, as it is a potent mechanical stimulus for bronchospasm. Recruitment maneuvers should be used to open up atelectasis.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11262175">
         <span class="h2">
          Cardiovascular deterioration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypotension can occur for many reasons under anesthesia (eg, hypovolemia or blood loss, vasodilation, myocardial depression), but some are more likely in children with asthma. The following should be considered in the event of cardiovascular deterioration:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reduced venous return
         </strong>
         – High airway pressures can result in reduced venous return. Treatment of bronchospasm or, if necessary, brief disconnection of the ventilator to relieve high intrathoracic pressure may help in this situation [
         <a href="#rid84">
          84
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anaphylaxis
         </strong>
         – Hypotension may result from anaphylaxis.
         <a class="drug drug_pediatric" data-topicid="13272" href="/z/d/drug information/13272.html" rel="external">
          Epinephrine
         </a>
         is a mainstay of treatment of anaphylaxis, along with H
         <sub>
          1
         </sub>
         and H
         <sub>
          2
         </sub>
         blockers and glucocorticoids. Treatment of anaphylaxis is discussed more fully separately. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment", section on 'Pharmacologic treatments'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5750.html" rel="external">
          "Anaphylaxis in infants", section on 'Epinephrine for first-aid treatment of anaphylaxis in the community'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adrenal insufficiency
         </strong>
         – Insidious hypotension in a child who has been taking oral or inhaled glucocorticoids may be due to adrenal insufficiency as a result of suppression of hypothalamic pituitary axis. Hyponatremia and hyperkalemia might be present. If adrenal insufficiency is suspected, stress dose glucocorticoid should be administered (0 to 3 years:
         <a class="drug drug_pediatric" data-topicid="13361" href="/z/d/drug information/13361.html" rel="external">
          hydrocortisone
         </a>
         25 mg IV; 3 to 12 years: hydrocortisone 50 mg IV; 12 years and older: hydrocortisone 100 mg IV). Treatment of adrenal insufficiency in children is discussed more fully separately. (See
         <a class="medical medical_review" href="/z/d/html/5815.html" rel="external">
          "Causes of central adrenal insufficiency in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5825.html" rel="external">
          "Treatment of adrenal insufficiency in children", section on 'Surgical procedures'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5815.html" rel="external">
          "Causes of central adrenal insufficiency in children", section on 'Chronic high-dose glucocorticoid therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H187479030">
         <span class="h1">
          EMERGENCE AND EXTUBATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchospasm can occur on emergence from anesthesia when the endotracheal tube (ETT) is in place and level of anesthesia is reduced. The goal should be to achieve a smooth, controlled emergence. In our clinical practice, we commonly perform deep removal of the airway (ETT or supraglottic airway [SGA]) in children who are at increased risk of perioperative respiratory adverse events (PRAE).
        </p>
        <p>
         Awake removal of the ETT in children has been shown to increase the incidence of persistent coughing and oxygen desaturation, while deep removal of the ETT increases the incidence of partial airway obstruction. Such obstructions are easily overcome by simple airway maneuvers (eg, chin lift or jaw thrust) and are not associated with desaturations [
         <a href="#rid1">
          1,85
         </a>
         ], as long as post-anesthesia care unit staff are competent in these simple airway maneuvers.
        </p>
        <p>
         Whereas deep removal of airway devices may result in a smoother emergence than awake removal, the risk of PRAEs may be similar.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a single-center randomized trial that compared awake versus deep extubation of the trachea in 100 children with increased airway susceptibility undergoing adenotonsillectomy, the rate of PRAEs were similar in the two groups [
         <a href="#rid85">
          85
         </a>
         ]. Children who were extubated awake showed a tendency toward more and longer episodes of very brief (&lt;10 seconds) desaturations to &lt;95 percent, but overall there was no evidence for an increased risk of oxygen desaturation following either technique. There was also no difference in the occurrence of laryngospasm or bronchospasm between children who were extubated awake as compared with those who were extubated while still at a surgical level of anesthesia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a single center randomized trial including 290 children with at least one risk factor for PRAE who underwent tonsillectomy with a supraglottic airway, the incidence of PRAEs was similar in children who had the SGA removed while deeply anesthetized versus removed when awake [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26419087">
         <span class="h1">
          POSTOPERATIVE MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The intraoperative course for the child with asthma dictates the postoperative course. If the intraoperative course is uneventful and pain, nausea, and pulmonary status are well controlled, the postoperative management is similar to the child without asthma.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postoperative pulmonary management
         </strong>
         – Maintenance oral and inhaled asthma medications should be continued postoperatively. In some cases, oral steroids will have to be replaced by intravenous (IV) steroids. Nebulized bronchodilators and glucocorticoids should be prescribed if the patient is unable to use a metered dose inhaler (MDI) in the postoperative period.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Adequate pain control, bronchodilator therapy, incentive spirometry for children who can cooperate, deep breathing maneuvers, and early mobilization are important to avoid postoperative pulmonary complications. (See
         <a class="medical medical_review" href="/z/d/html/6970.html" rel="external">
          "Strategies to reduce postoperative pulmonary complications in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If severe bronchospasm has occurred during anesthesia, delayed extubation and postoperative ventilation may be considered to allow time for maximal medical treatment, return of airway function, and perhaps recovery from neuromuscular blocking agents (NMBAs) without the need for reversal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If a child with ongoing severe wheezing is extubated, recovery in a pediatric intensive care unit or a step-down unit should be considered. A trial of high-flow humidified oxygen or noninvasive ventilation (NIV) may be beneficial in children with asthma who are wheezing after extubation. This is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">
          "Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postoperative pain management
         </strong>
         – Postoperative epidural analgesia may be beneficial, especially for patients having upper-abdominal and thoracic surgery. Effective epidural analgesia may reduce splinting, reduce atelectasis, maintain respiratory muscle function, and provide superior pain control [
         <a href="#rid87">
          87
         </a>
         ]. Nerve blocks (eg, intercostal or paravertebral blocks) may achieve similar goals in patients who cannot have epidural placement. (See
         <a class="medical medical_review" href="/z/d/html/127173.html" rel="external">
          "Approach to the management of acute perioperative pain in infants and children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Nonsteroidal antiinflammatory drugs (NSAIDs) should be used with caution in children with a history of aspirin-exacerbated respiratory disease (ie, asthma, chronic rhinosinusitis, and nasal polyposis). NSAIDs increase leukotriene production by cyclooxygenase inhibition and have been associated with bronchospasm, laryngospasm, rhinorrhea, and periorbital edema in susceptible children (see
         <a class="medical medical_review" href="/z/d/html/2082.html" rel="external">
          "NSAIDs (including aspirin): Allergic and pseudoallergic reactions"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/520.html" rel="external">
          "Aspirin-exacerbated respiratory disease"
         </a>
         ). However, the risk of postoperative NSAIDs causing bronchospasm is small [
         <a href="#rid88">
          88-90
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">
          Acetaminophen
         </a>
         /paracetamol use has been postulated to be a risk factor for asthma because this agent induces depletion of the antioxidant glutathione in lung tissue [
         <a href="#rid91">
          91
         </a>
         ]. However, a randomized controlled trial in 300 children with mild persistent asthma reported that as-needed use of acetaminophen was not associated with a higher incidence of asthma exacerbations or worse asthma control than as-needed use of
         <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">
          ibuprofen
         </a>
         [
         <a href="#rid92">
          92
         </a>
         ]. The possible association between prenatal exposure to acetaminophen and asthma is discussed more fully separately. (See
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma", section on 'Acetaminophen'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H272319675">
         <span class="h1">
          SPECIAL POPULATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H272319681">
         <span class="h2">
          Emergency surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Induction of anesthesia for an emergency procedure in the patient with asthma undergoing general anesthesia requires a balance between the need for rapid control of the airway and the avoidance of bronchospasm with intubation.
        </p>
        <p>
        </p>
        <p>
         Except in truly life-threatening emergencies, there is usually time to conduct a basic evaluation, to administer an inhaled bronchodilator, and to potentially administer perioperative systemic glucocorticoids, if required (see
         <a class="local">
          'Supplemental glucocorticoids'
         </a>
         above). A rapid preoperative assessment of the patient presenting for emergency surgery should at least include a brief history including identification of precipitating factors, medical management of asthma, degree of pulmonary disability, and previous episodes of bronchospasm under anesthesia.
        </p>
        <p>
         Patients who have sustained trauma may be hemodynamically unstable, making it difficult to achieve a deep level of anesthesia for endotracheal intubation. We usually perform a modified rapid sequence induction for children using cricoid pressure with gentle bag and mask ventilation, which is of particular importance in children with lung disease to avoid hypoxia. The bronchodilatory properties of
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         make a combination (sometimes referred to as "ketofol") of these drugs useful in this situation, depending upon patient hemodynamic stability. (See
         <a class="local">
          'Induction of anesthesia'
         </a>
         above.)
        </p>
        <p>
         Injuries of the chest and airway can mimic the onset of bronchospasm. Conditions such as tension pneumothorax, tracheobronchial disruption, pulmonary hemorrhage, and ball-valve obstruction of the endotracheal tube by foreign bodies or blood clots should be quickly ruled out by Advanced Trauma Life Support (ATLS) survey. (See
         <a class="medical medical_review" href="/z/d/html/6568.html" rel="external">
          "Thoracic trauma in children: Initial stabilization and evaluation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H272319893">
         <span class="h2">
          Patients with asthma and with increased intracranial pressure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ventilation for the child with asthma and with increased intracranial pressure (ICP) can be especially challenging. Hyperventilation to decrease ICP may be difficult and may result in hyperinflation and barotrauma. Volatile anesthetics, especially in higher concentrations and without hyperventilation, can decrease cerebral perfusion pressure and increase ICP.
        </p>
        <p>
         Similar to patients without increased ICP,
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         is the induction agent of choice in the hemodynamically stable patient if measures are used to maintain blood pressure and therefore cerebral perfusion pressure.
         <a class="drug drug_pediatric" data-topicid="12907" href="/z/d/drug information/12907.html" rel="external">
          Etomidate
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          ketamine
         </a>
         are alternative induction agents for patients who are hemodynamically unstable; the effects of ketamine on cerebral physiology are uncertain. Choice of induction agents is discussed separately. (See
         <a class="local">
          'Intravenous induction agents'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/93391.html" rel="external">
          "Anesthesia for craniotomy in adults", section on 'Choice of induction agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H272320011">
         <span class="h2">
          Ambulatory surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with well controlled asthma and compliance with medications and treatments are suitable candidates for ambulatory surgery. If the surgery and anesthetic course are uneventful and pain, nausea, and respiratory status are well controlled, the child with asthma can be discharged to home without further intervention.
        </p>
        <p class="headingAnchor" id="H3315284991">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/122166.html" rel="external">
          "Society guideline links: Pediatric anesthesia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H272320018">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative management
         </strong>
         – Asthma control should be optimized prior to anesthesia. If possible, we assess patients with asthma one to two weeks prior to elective surgery to allow time for modification of treatment, if necessary. Patients should continue usual asthma treatment through the perioperative period. (See
         <a class="local">
          'Induction of anesthesia'
         </a>
         above and
         <a class="local">
          'Preoperative medication management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For children with very poorly controlled asthma requiring endotracheal intubation, we suggest a course of supplemental glucocorticoids (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). In consultation with an asthma specialist or primary care clinician, we usually administer
         <a class="drug drug_pediatric" data-topicid="12725" href="/z/d/drug information/12725.html" rel="external">
          prednisone
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12723" href="/z/d/drug information/12723.html" rel="external">
          prednisolone
         </a>
         orally 1 mg/kg (maximum 50 mg) once a day for four days. (See
         <a class="local">
          'Supplemental glucocorticoids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Induction and airway management
         </strong>
         – For most children with asthma, we suggest intravenous (IV) induction rather than inhalation induction as this may reduce the risk of perioperative respiratory adverse events (PRAE) in at-risk children (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). For most hemodynamically stable children undergoing general anesthesia, we suggest induction with
         <a class="drug drug_pediatric" data-topicid="12741" href="/z/d/drug information/12741.html" rel="external">
          propofol
         </a>
         rather than other agents, since propofol prevents bronchospasm in response to intubation (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ).
         <a class="drug drug_pediatric" data-topicid="13398" href="/z/d/drug information/13398.html" rel="external">
          Ketamine
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12907" href="/z/d/drug information/12907.html" rel="external">
          etomidate
         </a>
         may be preferred for patients who are hemodynamically unstable. Unlike etomidate, ketamine has bronchodilatory properties. (See
         <a class="local">
          'Induction of anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Endotracheal intubation is a potent stimulus for bronchospasm, especially under light levels of anesthesia. When possible, we suggest use of mask ventilation or a supraglottic airway for airway management for general anesthesia rather than endotracheal intubation (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Endotracheal intubation is associated with a higher risk of PRAE. (See
         <a class="local">
          'Airway management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintenance anesthetics
         </strong>
         – For most children with asthma, total IV anesthesia or
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         ,
         <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">
          isoflurane
         </a>
         , or halothane can be used for maintenance of anesthesia.
         <a class="drug drug_pediatric" data-topicid="134454" href="/z/d/drug information/134454.html" rel="external">
          Desflurane
         </a>
         is an airway irritant and should not be used in asthmatic children or children at an increased risk for PRAE . (See
         <a class="local">
          'Inhalation agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Neuromuscular blocking agents (NMBAs)
         </strong>
         – For children with asthma, NMBAs that do not release appreciable amounts of histamine (eg,
         <a class="drug drug_pediatric" data-topicid="12774" href="/z/d/drug information/12774.html" rel="external">
          rocuronium
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13160" href="/z/d/drug information/13160.html" rel="external">
          cisatracurium
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="12877" href="/z/d/drug information/12877.html" rel="external">
          vecuronium
         </a>
         ) are preferred over those that do (eg,
         <a class="drug drug_pediatric" data-topicid="12862" href="/z/d/drug information/12862.html" rel="external">
          atracurium
         </a>
         and mivacurium).
         <a class="drug drug_pediatric" data-topicid="12640" href="/z/d/drug information/12640.html" rel="external">
          Neostigmine
         </a>
         used for reversal of muscle relaxants can rarely cause bronchospasm. We suggest the use of an NMBA for endotracheal intubation, rather than intubation without an NMBA (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ), as intubation with an NMBA is associated with less PRAEs. (See
         <a class="local">
          'Airway management'
         </a>
         above and
         <a class="local">
          'Neuromuscular blocking agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Opioids
         </strong>
         –
         <a class="drug drug_pediatric" data-topicid="16024" href="/z/d/drug information/16024.html" rel="external">
          Morphine
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="12580" href="/z/d/drug information/12580.html" rel="external">
          meperidine
         </a>
         can release histamine when given in high doses or very rapidly. Other synthetic opioids are preferred in children with asthma because they do not release clinically relevant amounts of histamine. (See
         <a class="local">
          'Opioids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Ventilation
         </strong>
         – Ventilation for patients with asthma during anesthesia should include controlled hypoventilation with low respiratory rates, reduced inspiratory time, increased expiratory time, moderate tidal volumes, and cautious use of positive end-expiratory pressure, aiming to avoid hyperinflation, air trapping, and barotrauma. (See
         <a class="local">
          'Ventilation during anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment of intraoperative bronchospasm
         </strong>
         – If bronchospasm occurs during anesthesia, treatment should include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         FiO
         <sub>
          2
         </sub>
         100 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cautious hand ventilation (low frequency allowing adequate expiration)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Deepened anesthesia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with bronchospasm that persists after deepening the anesthesia (preferentially with volatile anesthetic agents) should receive short-acting beta
         <sub>
          2
         </sub>
         agonist therapy (eg,
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         8 to 10 puffs via metered dose inhaler or 2.5 mg via nebulizer). More severe bronchospasm may require intervention with IV albuterol,
         <a class="drug drug_pediatric" data-topicid="13338" href="/z/d/drug information/13338.html" rel="external">
          glycopyrrolate
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12875" href="/z/d/drug information/12875.html" rel="external">
          atropine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13272" href="/z/d/drug information/13272.html" rel="external">
          epinephrine
         </a>
         , magnesium, and steroids. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Emergence from anesthesia
         </strong>
         – Aim for smooth emergence from anesthesia. We often perform extubation or removal of an SGA with the child still deeply anesthetized (as opposed to awake) to avoid bronchospasm during emergence. Patients with a complicated intraoperative course may benefit from continued postoperative intubation and ventilation. Postoperative noninvasive positive pressure ventilation can be used for extubated patients who need ventilatory support. (See
         <a class="local">
          'Emergence and extubation'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           von Ungern-Sternberg BS, Boda K, Chambers NA, et al. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet 2010; 376:773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hollevoet I, Herregods S, Vereecke H, et al. Medication in the perioperative period: stop or continue? A review. Acta Anaesthesiol Belg 2011; 62:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mercado DL, Petty BG. Perioperative medication management. Med Clin North Am 2003; 87:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kabalin CS, Yarnold PR, Grammer LC. Low complication rate of corticosteroid-treated asthmatics undergoing surgical procedures. Arch Intern Med 1995; 155:1379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Su FW, Beckman DB, Yarnold PA, Grammer LC. Low incidence of complications in asthmatic patients treated with preoperative corticosteroids. Allergy Asthma Proc 2004; 25:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pien LC, Grammer LC, Patterson R. Minimal complications in a surgical population with severe asthma receiving prophylactic corticosteroids. J Allergy Clin Immunol 1988; 82:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Ungern-Sternberg BS, Habre W, Erb TO, Heaney M. Salbutamol premedication in children with a recent respiratory tract infection. Paediatr Anaesth 2009; 19:1064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scalfaro P, Sly PD, Sims C, Habre W. Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children. Anesth Analg 2001; 93:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Ungern-Sternberg BS, Sommerfield D, Slevin L, et al. Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial. JAMA Pediatr 2019; 173:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Habre W, Petak F. Anaesthesia management of patients with airway susceptibilities: what have we learnt from animal models? Eur J Anaesthesiol 2013; 30:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamakage M, Iwasaki S, Satoh JI, Namiki A. Inhibitory effects of the alpha-2 adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs. Eur J Anaesthesiol 2008; 25:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groeben H, Mitzner W, Brown RH. Effects of the alpha2-adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs. Anesthesiology 2004; 100:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dinh Xuan AT, Matran R, Regnard J, et al. Comparative effects of rilmenidine and clonidine on bronchial responses to histamine in asthmatic subjects. Br J Clin Pharmacol 1988; 26:703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dinh Xuan AT, Regnard J, Matran R, et al. Effects of clonidine on bronchial responses to histamine in normal and asthmatic subjects. Eur Respir J 1988; 1:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cozzi G, Lega S, Giorgi R, Barbi E. Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation. Ann Emerg Med 2017; 69:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mamie C, Habre W, Delhumeau C, et al. Incidence and risk factors of perioperative respiratory adverse events in children undergoing elective surgery. Paediatr Anaesth 2004; 14:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Habre W, Disma N, Virag K, et al. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med 2017; 5:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bordet F, Allaouchiche B, Lansiaux S, et al. Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth 2002; 12:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tait AR, Pandit UA, Voepel-Lewis T, et al. Use of the laryngeal mask airway in children with upper respiratory tract infections: a comparison with endotracheal intubation. Anesth Analg 1998; 86:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drake-Brockman TF, Ramgolam A, Zhang G, et al. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial. Lancet 2017; 389:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox RG, Barker GA, Bohn DJ. Efficacy, results, and complications of mechanical ventilation in children with status asthmaticus. Pediatr Pulmonol 1991; 11:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chambers NA, Ramgolam A, Sommerfield D, et al. Cuffed vs. uncuffed tracheal tubes in children: a randomised controlled trial comparing leak, tidal volume and complications. Anaesthesia 2018; 73:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calder A, Hegarty M, Erb TO, von Ungern-Sternberg BS. Predictors of postoperative sore throat in intubated children. Paediatr Anaesth 2012; 22:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramgolam A, Hall GL, Zhang G, et al. Inhalational versus Intravenous Induction of Anesthesia in Children with a High Risk of Perioperative Respiratory Adverse Events: A Randomized Controlled Trial. Anesthesiology 2018; 128:1065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter LL, Blaauwendraad SM, Pieters BM. Respiratory and hemodynamic perioperative adverse events in intravenous versus inhalational induction in pediatric anesthesia: A systematic review and meta-analysis. Paediatr Anaesth 2020; 30:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groeben H, Silvanus MT, Beste M, Peters J. Both intravenous and inhaled lidocaine attenuate reflex bronchoconstriction but at different plasma concentrations. Am J Respir Crit Care Med 1999; 159:530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adamzik M, Groeben H, Farahani R, et al. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth Analg 2007; 104:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groeben H, Foster WM, Brown RH. Intravenous lidocaine and oral mexiletine block reflex bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1996; 154:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erb TO, von Ungern-Sternberg BS, Keller K, Frei FJ. The effect of intravenous lidocaine on laryngeal and respiratory reflex responses in anaesthetised children*. Anaesthesia 2013; 68:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller WC, Awe R. Effect of nebulized lidocaine on reactive airways. Am Rev Respir Dis 1975; 111:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss EB, Patwardhan AV. The response to lidocaine in bronchial asthma. Chest 1977; 72:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fish JE, Peterman VI. Effects of inhaled lidocaine on airway function in asthmatic subjects. Respiration 1979; 37:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamilton ND, Hegarty M, Calder A, et al. Does topical lidocaine before tracheal intubation attenuate airway responses in children? An observational audit. Paediatr Anaesth 2012; 22:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eames WO, Rooke GA, Wu RS, Bishop MJ. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology 1996; 84:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu RS, Wu KC, Sum DC, Bishop MJ. Comparative effects of thiopentone and propofol on respiratory resistance after tracheal intubation. Br J Anaesth 1996; 77:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forget P, Pirson E, Scholtès JL. Anaphylactic bronchospasm due to propofol. Anaesth Intensive Care 2009; 37:865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           You BC, Jang AS, Han JS, et al. A case of propofol-induced oropharyngeal angioedema and bronchospasm. Allergy Asthma Immunol Res 2012; 4:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy A, Campbell DE, Baines D, Mehr S. Allergic reactions to propofol in egg-allergic children. Anesth Analg 2011; 113:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirshman CA, Bergman NA. Factors influencing intrapulmonary airway calibre during anaesthesia. Br J Anaesth 1990; 65:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pedersen CM, Thirstrup S, Nielsen-Kudsk JE. Smooth muscle relaxant effects of propofol and ketamine in isolated guinea-pig trachea. Eur J Pharmacol 1993; 238:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizov R, Brown RH, Weiss YS, et al. Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial. Anesthesiology 1995; 82:1111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med 2005; 46:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database Syst Rev 2012; 11:CD009293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lundy JB, Slane ML, Frizzi JD. Acute adrenal insufficiency after a single dose of etomidate. J Intensive Care Med 2007; 22:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rooke GA, Choi JH, Bishop MJ. The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation. Anesthesiology 1997; 86:1294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Habre W, Scalfaro P, Sims C, et al. Respiratory mechanics during sevoflurane anesthesia in children with and without asthma. Anesth Analg 1999; 89:1177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lele E, Petak F, Carnesecchi S, et al. The protective effects of volatile anesthestics against the bronchoconstriction induced by an allergic reaction in sensitized rabbit pups. Anesth Analg 2013; 116:1257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz SH. Treatment of status asthmaticus with halothane. JAMA 1984; 251:2688.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dikmen Y, Eminoglu E, Salihoglu Z, Demiroluk S. Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia. Anaesthesia 2003; 58:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Ungern-Sternberg BS, Saudan S, Petak F, et al. Desflurane but not sevoflurane impairs airway and respiratory tissue mechanics in children with susceptible airways. Anesthesiology 2008; 108:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyktari V, Papaioannou A, Volakakis N, et al. Respiratory resistance during anaesthesia with isoflurane, sevoflurane, and desflurane: a randomized clinical trial. Br J Anaesth 2011; 107:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naguib M, Samarkandi AH, Bakhamees HS, et al. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 1995; 75:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laxenaire MC, Mertes PM, Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Basta SJ. Modulation of histamine release by neuromuscular-blocking drugs. Curr Opin Anesthesiol 1992; 5:572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hazizaj A, Hatija A. Bronchospasm caused by neostigmine. Eur J Anaesthesiol 2006; 23:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshioka N, Hanazaki M, Fujita Y, et al. Effect of sugammadex on bronchial smooth muscle function in rats. J Smooth Muscle Res 2012; 48:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amao R, Zornow MH, Cowan RM, et al. Use of sugammadex in patients with a history of pulmonary disease. J Clin Anesth 2012; 24:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia 2014; 69:1251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ue KL, Kasternow B, Wagner A, et al. Sugammadex: An emerging trigger of intraoperative anaphylaxis. Ann Allergy Asthma Immunol 2016; 117:714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Philbin DM, Moss J, Akins CW, et al. The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology 1981; 55:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prieto-Lastra L, Iglesias-Cadarso A, Reaño-Martos MM, et al. Pharmacological stimuli in asthma/urticaria. Allergol Immunopathol (Madr) 2006; 34:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eschenbacher WL, Bethel RA, Boushey HA, Sheppard D. Morphine sulfate inhibits bronchoconstriction in subjects with mild asthma whose responses are inhibited by atropine. Am Rev Respir Dis 1984; 130:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosow CE, Moss J, Philbin DM, Savarese JJ. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 1982; 56:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guedes AG, Papich MG, Rude EP, Rider MA. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs. J Vet Pharmacol Ther 2007; 30:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flacke JW, Flacke WE, Bloor BC, et al. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987; 66:723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khosla S, Kunjummen B, Khaleel R, et al. Safety of therapeutic beta-blockade in patients with coexisting bronchospastic airway disease and coronary artery disease. Am J Ther 2003; 10:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morales DR, Jackson C, Lipworth BJ, et al. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials. Chest 2014; 145:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stather DR, Stewart TE. Clinical review: Mechanical ventilation in severe asthma. Crit Care 2005; 9:581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 2006; 144:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sabato K, Hanson JH. Mechanical ventilation for children with status asthmaticus. Respir Care Clin N Am 2000; 6:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarnaik AP, Daphtary KM, Meert KL, et al. Pressure-controlled ventilation in children with severe status asthmaticus. Pediatr Crit Care Med 2004; 5:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhand R, Tobin MJ. Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients. Eur Respir J 1996; 9:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazela J, Polin RA. Aerosol delivery to ventilated newborn infants: historical challenges and new directions. Eur J Pediatr 2011; 170:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holland A, Smith F, Penny K, et al. Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units. Cochrane Database Syst Rev 2013; :CD008863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacIntyre NR, Silver RM, Miller CW, et al. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985; 13:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson N, Schultz A, Ditcham W, von Ungern-Sternberg BS. Assessment of different techniques for the administration of inhaled salbutamol in children breathing spontaneously via tracheal tubes, supraglottic airway devices, and tracheostomies. Paediatr Anaesth 2020; 30:1363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gal TJ, Suratt PM. Atropine and glycopyrrolate effects on lung mechanics in normal man. Anesth Analg 1981; 60:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008; 63 Suppl 4:iv1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Travers AH, Jones AP, Camargo CA Jr, et al. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database Syst Rev 2012; 12:CD010256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuxen DV, Lane S. The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis 1987; 136:872.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shan Z, Rong Y, Yang W, et al. Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: a systematic review and meta-analysis. Respir Med 2013; 107:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; :CD001490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodrigo GJ, Rodrigo C, Pollack CV, Rowe B. Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review. Chest 2003; 123:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shapiro JM. Management of respiratory failure in status asthmaticus. Am J Respir Med 2002; 1:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Ungern-Sternberg BS, Davies K, Hegarty M, et al. The effect of deep vs. awake extubation on respiratory complications in high-risk children undergoing adenotonsillectomy: a randomised controlled trial. Eur J Anaesthesiol 2013; 30:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramgolam A, Hall GL, Zhang G, et al. Deep or awake removal of laryngeal mask airway in children at risk of respiratory adverse events undergoing tonsillectomy-a randomised controlled trial. Br J Anaesth 2018; 120:571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manion SC, Brennan TJ. Thoracic epidural analgesia and acute pain management. Anesthesiology 2011; 115:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Short JA, Barr CA, Palmer CD, et al. Use of diclofenac in children with asthma. Anaesthesia 2000; 55:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McBride JT. The association of acetaminophen and asthma prevalence and severity. Pediatrics 2011; 128:1181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Debley JS, Carter ER, Gibson RL, et al. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. J Pediatr 2005; 147:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dimova S, Hoet PH, Dinsdale D, Nemery B. Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol 2005; 37:1727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheehan WJ, Mauger DT, Paul IM, et al. Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma. N Engl J Med 2016; 375:619.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 91646 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20816545" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22379758" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Medication in the perioperative period: stop or continue? A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12575883" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Perioperative medication management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7794086" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Low complication rate of corticosteroid-treated asthmatics undergoing surgical procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15603206" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Low incidence of complications in asthmatic patients treated with preoperative corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3171010" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Minimal complications in a surgical population with severe asthma receiving prophylactic corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19694973" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Salbutamol premedication in children with a recent respiratory tract infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11574353" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31009034" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23736092" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Anaesthesia management of patients with airway susceptibilities: what have we learnt from animal models?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17888193" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Inhibitory effects of the alpha-2 adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14739811" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Effects of the alpha2-adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2907408" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Comparative effects of rilmenidine and clonidine on bronchial responses to histamine in asthmatic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3396674" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Effects of clonidine on bronchial responses to histamine in normal and asthmatic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27776827" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14996260" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Incidence and risk factors of perioperative respiratory adverse events in children undergoing elective surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28363725" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12519134" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Risk factors for airway complications during general anaesthesia in paediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9539588" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Use of the laryngeal mask airway in children with upper respiratory tract infections: a comparison with endotracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28108038" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1758729" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Efficacy, results, and complications of mechanical ventilation in children with status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29168575" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Cuffed vs. uncuffed tracheal tubes in children: a randomised controlled trial comparing leak, tidal volume and complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22066487" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Predictors of postoperative sore throat in intubated children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29498948" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Inhalational versus Intravenous Induction of Anesthesia in Children with a High Risk of Perioperative Respiratory Adverse Events: A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32358815" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Respiratory and hemodynamic perioperative adverse events in intravenous versus inhalational induction in pediatric anesthesia: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9927369" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Both intravenous and inhaled lidocaine attenuate reflex bronchoconstriction but at different plasma concentrations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17179265" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8887580" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Intravenous lidocaine and oral mexiletine block reflex bronchoconstriction in asthmatic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23061716" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The effect of intravenous lidocaine on laryngeal and respiratory reflex responses in anaesthetised children*.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1137242" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Effect of nebulized lidocaine on reactive airways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/332458" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The response to lidocaine in bronchial asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/472500" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Effects of inhaled lidocaine on airway function in asthmatic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22211867" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Does topical lidocaine before tracheal intubation attenuate airway responses in children? An observational audit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8669670" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9014625" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Comparative effects of thiopentone and propofol on respiratory resistance after tracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19775064" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Anaphylactic bronchospasm due to propofol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22211170" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : A case of propofol-induced oropharyngeal angioedema and bronchospasm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21467558" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Allergic reactions to propofol in egg-allergic children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2200482" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Factors influencing intrapulmonary airway calibre during anaesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8405085" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Smooth muscle relaxant effects of propofol and ketamine in isolated guinea-pig trachea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7741285" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15988425" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23152273" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Ketamine for management of acute exacerbations of asthma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17456730" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Acute adrenal insufficiency after a single dose of etomidate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9197298" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10553830" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Respiratory mechanics during sevoflurane anesthesia in children with and without asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23592610" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The protective effects of volatile anesthestics against the bronchoconstriction induced by an allergic reaction in sensitized rabbit pups.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6716600" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Treatment of status asthmaticus with halothane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12859465" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18212566" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Desflurane but not sevoflurane impairs airway and respiratory tissue mechanics in children with susceptible airways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21665899" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Respiratory resistance during anaesthesia with isoflurane, sevoflurane, and desflurane: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7577286" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11878723" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Anaphylaxis during anaesthesia. Results of a two-year survey in France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Modulation of histamine release by neuromuscular-blocking drugs
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16390575" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Bronchospasm caused by neostigmine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22850404" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Effect of sugammadex on bronchial smooth muscle function in rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22608583" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Use of sugammadex in patients with a history of pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24848211" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Hypersensitivity associated with sugammadex administration: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27789121" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Sugammadex: An emerging trigger of intraoperative anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6115596" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17064652" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Pharmacological stimuli in asthma/urticaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6476586" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Morphine sulfate inhibits bronchoconstriction in subjects with mild asthma whose responses are inhibited by atropine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6172999" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Histamine release during morphine and fentanyl anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17991219" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2440351" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Histamine release by four narcotics: a double-blind study in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12522520" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Safety of therapeutic beta-blockade in patients with coexisting bronchospastic airway disease and coronary artery disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24202435" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Adverse respiratory effect of acuteβ-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16356242" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Clinical review: Mechanical ventilation in severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16618955" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10639562" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Mechanical ventilation for children with status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14987342" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Pressure-controlled ventilation in children with severe status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8730023" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20878336" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Aerosol delivery to ventilated newborn infants: historical challenges and new directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23740736" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3967508" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Aerosol delivery in intubated, mechanically ventilated patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32997848" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Assessment of different techniques for the administration of inhaled salbutamol in children breathing spontaneously via tracheal tubes, supraglottic airway devices, and tracheostomies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7469088" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Atropine and glycopyrrolate effects on lung mechanics in normal man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18463203" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : British Guideline on the Management of Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23235686" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3662241" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23290189" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10796650" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Magnesium sulfate for treating exacerbations of acute asthma in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12628893" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14720028" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Management of respiratory failure in status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23344124" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : The effect of deep vs. awake extubation on respiratory complications in high-risk children undergoing adenotonsillectomy: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29452814" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Deep or awake removal of laryngeal mask airway in children at risk of respiratory adverse events undergoing tonsillectomy-a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21606825" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Thoracic epidural analgesia and acute pain management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10781118" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Use of diclofenac in children with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22065272" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : The association of acetaminophen and asthma prevalence and severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16126056" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15878691" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27532828" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
